BOM/539523 (BOM/539523)

Bombay Stock Exchange: BOM/539523 · INR

₹5,074

-81.85 (-1.6%)· Recorded snapshot

Market cap	606.2B
Revenue (ttm)	150.8B
Net income (ttm)	21.6B
EPS (ttm)	₹180
P/E (trailing)	28.1x
P/E (forward)	25.2x
Dividend	₹53.0 (1.04%)
Volume	1,994

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 150.8B
Net income (ttm): 21.6B
EPS (ttm): ₹180
P/E (trailing): 28.1x
P/E (forward): 25.2x
Market cap: 606.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E25.2

P25 n/aP50 n/aP75 n/a

Trailing P/E28.1

P25 n/aP50 n/aP75 n/a

ROE17.6

P25 n/aP50 n/aP75 n/a

ROIC16.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/539523 indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

INR

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-06
Employees	19,346
Employees change	561
Employees growth	2.99%
Enterprise value	INR 591.3B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1973
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	INE540L01014
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Market cap	INR 606.2B
Next earnings date	2026-11-06
Price	INR 5,074.15
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bom/539523
Website	https://www.alkemlabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	26.59x
Average P/E ratio (10Y)	29.4x
Average P/E ratio (3Y)	30.28x
Average P/E ratio (5Y)	30.93x
Earnings yield	3.56%
EV/Earnings	27.41x
EV/EBIT	22.62x
EV/EBITDA	19.83x
EV/FCF	43.94x
EV/Sales	3.92x
FCF / EV yield	2.28%
FCF yield	2.22%
Forward P/E	25.17x
Graham number	2209.16266
Graham upside	-56.46%
Industry forward P/E	33.08x
Industry P/E	38.9x
Lynch fair value	INR 1,038.94
Lynch upside	-79.52%
P/(FCF - SBC) ratio	45.21x
P/(OCF - SBC) ratio	30.96x
P/B ratio	4.22x
P/E ratio	28.12x
P/FCF ratio	45.04x
P/OCF ratio	30.88x
P/S ratio	4.02x
Price / tangible book value	4.7x
Price/EBITDA ratio	20.71x
Sector forward P/E	36.12x
Sector P/E	45.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	17.35%
EBITDA margin	19.4%
Effective tax rate	23.19%
FCF margin	9.15%
Gross margin	64.8%
Operating margin	17.35%
Pretax margin	19.03%
Profit margin	14.31%
Profit per employee	INR 1.1M
Profitable quarters	49
Profitable years	17
Revenue per employee	INR 7.8M
ROA	8.43%
ROA (5Y)	7.87%
ROCE	16.17%
ROE	17.56%
ROE (5Y)	17.24%
ROIC	16.29%
ROIC (5Y)	17.45%
SBC / revenue	0.03%
Tax / revenue	4.41%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-5.56%
EPS growth (Q)	-21.72%
EPS growth (QoQ)	119.98%
EPS growth 10Y	11.74%
EPS growth 3Y	23.58%
EPS growth 5Y	5.75%
EPS growth years	3
FCF growth	8.77%
FCF growth 3Y	-2.45%
FCF growth 5Y	4.69%
Gross profit growth	17.99%
Gross profit growth (Q)	15.4%
Gross profit growth 3Y	12.49%
Gross profit growth 5Y	11.51%
Net income growth	-5.56%
Net income growth (Q)	-21.72%
Net income growth (QoQ)	119.89%
Net income growth 3Y	23.58%
Net income growth 5Y	5.75%
Net income growth years	3
OCF growth	2.62%
OCF growth 10Y	10.46%
OCF growth 3Y	5.27%
OCF growth 5Y	9.19%
Operating income growth	14.98%
Operating income growth (Q)	2.22%
Operating income growth 3Y	20.12%
Operating income growth 5Y	8.47%
Revenue growth	13.36%
Revenue growth (Q)	10.95%
Revenue growth (QoQ)	3.8%
Revenue growth 10Y	11.15%
Revenue growth 3Y	7.94%
Revenue growth 5Y	9.44%
Revenue growth quarters	7
Revenue growth years	16

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -6.2B
Depreciation and amortization	INR 3.1B
EBIT	INR 26.2B
EBITDA	INR 29.3B
EPS	INR 180.45
Financing cash flow	INR -5B
Free cash flow	INR 13.5B
Free cash flow minus SBC	INR 13.4B
Gross profit	INR 97.7B
Income taxes	INR 6.7B
Investing cash flow	INR -16.7B
Net borrowing	INR 2.1B
Net cash flow	INR -2.2B
Net income	INR 21.6B
Operating cash flow minus SBC	INR 19.6B
Operating income	INR 26.2B
Revenue	INR 150.8B
Stock-based compensation	INR 48.7M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 1,155.87
Debt / EBITDA	0.69
Debt / equity	0.14
Debt / FCF	1.52
Interest coverage	16.62
Net cash (debt)	INR 20.1B
Net cash / market cap	3.32%
Net cash growth	-15.97%
Net debt / EBITDA	-0.69
Net debt / equity	-0.14
Net debt / FCF	-1.5
Piotroski F-Score	4
Shareholders' equity	INR 143.5B
Tangible book value	INR 129B
Tangible book value per share	INR 1,078.56
Total cash	INR 40.6B
Total debt	INR 20.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.76
Current ratio	2.55
Inventory turnover	1.69
Quick ratio	1.5
Working capital	INR 74.3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0%
Dividend growth	17.78%
Dividend growth (10Y)	12.94%
Dividend growth (3Y)	1.96%
Dividend growth (5Y)	12.05%
Dividend growth years	1
Dividend payment date	2026-09-26
Dividend payment years	11
Dividend payout frequency	Semi-Annual
Dividend per share	INR 53.00
Dividend yield	1.05%
Ex-dividend date	2026-08-07
Last dividend	INR 10.00
Payout ratio	29.37%
Shareholder yield	1.05%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	218.63%
10Y return CAGR	13.36%
10Y total return	250.23%
150-day SMA	INR 5,389.31
1D price change	-1.59%
1M price change	-2.16%
1M total return	-2.16%
1W price change	3.84%
1W total return	3.84%
1Y price change	-5.76%
1Y return CAGR	-4.83%
1Y total return	-4.83%
20-day SMA	INR 5,146.81
200-day SMA	INR 5,447.49
3M price change	-8.16%
3M total return	-7.99%
3Y price change	40.26%
3Y return CAGR	12.94%
3Y total return	44.07%
50-day SMA	INR 5,233.50
50-day SMA vs 200-day SMA	50under200
52-week high	INR 5,933.00
52-week high date	2026-01-13
52-week low	INR 4,879.85
52-week low date	2026-10-22
5Y price change	38.19%
5Y return CAGR	7.78%
5Y total return	45.45%
6M price change	-3.6%
6M total return	-3.43%
All-time high	INR 6,440.00
All-time high date	2024-09-17
All-time low	INR 1,175.00
All-time low date	2016-05-02
Average true range (ATR)	INR 127.21
Average volume	11.6K
Change from 52-week high	-14.48%
Change from 52-week low	3.98%
Change from all-time high	-19.94%
Change from all-time low	338.81%
Change from open	0.27%
Day's gap	-1.85%
Dollar volume	INR 10.1M
High price	INR 5,075.55
Low price	INR 5,011.50
Monthly RSI	47.03
Open price	INR 5,060.70
Position in 52-week range	97.81%
Previous close	INR 5,156.00
Price vs 150-day SMA	-4.33%
Price vs 20-day SMA	0.18%
Price vs 200-day SMA	-5.35%
Price vs 50-day SMA	-1.48%
Relative volume	0.15
RSI	45.27
Sharpe ratio	-0.42
Sharpe ratio (3Y)	0.47
Sharpe ratio (5Y)	0.21
Sortino ratio	-0.33
Sortino ratio (3Y)	0.94
Sortino ratio (5Y)	0.55
Volume	2K
Weekly RSI	42.84
YTD price change	-6.34%
YTD total return	-5.42%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46.1M
Shares change (QoQ)	-0.04%
Shares change (YoY)	-0%
Shares held by insiders	43.12%
Shares held by institutions	28.7%

Deeper analysis on BOM/539523

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/539523 report

Is a complete BOM/539523 research report available?

No complete published report is available for bom/539523 (BOM/539523) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/539523 (BOM/539523)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/539523

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/539523 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/539523

Frequently asked questions